Left ventricular myocardial focal involvement and sudden death risk in cardiac sarcoidosis

N.D. Oryshchyn, Yu.A. Ivaniv, N.V. Lozynska, O.Ya. Soroka, S.S. Pavlyk, Yu.O. Palamarchuk, M.S. Sorokivskyj

References 

1. Aizer A., Stern E.H., Gomes J.A. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis // Am. J. Cardiol.– 2005.– Vol. 96.– P. 276–282.
2. Cheong B.Y., Muthupillai R., Nemeth M. et al. The utility of delayed-enhancement magnetic resonance imaging for identifing non-ischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis //  Vasc. Diffuse Lung Dis.– 2009 – Vol. 26.– P. 39–46.
3. Epstein A.E., DiMarco J.P., Ellenbogen K.A. et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice  Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and  Society of Thoracic Surgeons. // J. Am. Coll. Cardiol.– 2008.– Vol. 51.– P. e1–62.
4. Evanchan J.P., Crouser E.D., Kalbfleisch S.J. Cardiac Sarcoidosis: Recent Advances in Diagnosis and Treatment and an Argument for the Need for a Systematic Multidisciplinary Approach to Management // J. Inn. Cardiac Rhythm   Management.– 2013.– Vol. 4.– P. 1160–1174.
5. Hiraga H., Yuwai K., Hiroe M. et al. Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases from the Japanese Ministry of Health and Welfare // Japanese Ministry of Health and Welfare.– 1993.– Р. 23–24.
6. Kato Y., Morimoto S., Uemura A. et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block // Sarcoidosis Vasc. Diffuse Lung Dis.– 2003.– Vol. 20.– P.133–137.
7. Mehta D., Lubitz S.A., Frankel Z et al. Cardiac involvement in patients with sarcoidosis // Chest.– 2008.– Vol. 133.– P. 1426–1435.
8. Mehta D., Mori N., Goldbarg S.H. et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: clinical perspective // Circ. Arrhythm. Electrophysiol.– 2011.– Vol. 4.– P. 43–48.
9. Patel M.R., Cawley P.J., Heitner J.F. et al. Detection of myocardial damage in patients with sarcoidosis // Circulation.– 2009.– Vol. 120.– P. 1969–1977.
10. Roberts W.C., McAllister H.A., Ferrans V.J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11) // Am. J. Med.– 1977.– Vol. 63.– P. 86–    108.
11. Smedema J.P., Snoep G., van Kroonenburgh M.P. et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis // J. Am. Coll. Cardiol.– 2005.– Vol. 45.– P. 1683–1690.
12. Soejima K., Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities // J. Cardiovasc. Electrophysiol.– 2009.– Vol. 20.– P. 578–583.
13. Tadamura E., Yamamuro M., Kubo S. et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging // Am. J. Roentgenol.– 2005.– Vol. 185.– P. 110–115.
14. Youssef G., Beanlands R.S., Birnie D.H. et al. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment // Heart.– 2011.– Vol. 97.– P. 2078–2087.
15. Yodogawa K., Seino Y., Ohara T. et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis // Ann. Noninvasive Electrocardiol.– 2011.– Vol. 16.– P. 140–147.